Combination therapy of anti-HER3 antibodies

US9180185B2 · kind B2 · utility

Assignee

• Hoffmann-La Roche Inc. · US

Inventors

• Frieder Bauss · Lambsheim, DE
• Birgit Bossenmaier · Hanerau-Hademarschen, DE
• Thomas Friess · Planegg, DE
• Christian Gerdes · Küsnacht (ZH), CH
• Max Hasmann · Schwanau, DE
• Marlene Thomas · Penzberg, DE
• Martin Weisser · Penzberg, DE

Key dates

• Filing date: Jan 9, 2014
• Grant date: Nov 10, 2015
• Expiry date: Jan 9, 2034

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07K2317/92
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The present invention relates to the combination therapy of anti-HER3 antibodies with certain anti-HER antibodies.